Never miss an update from Universidad de Alicante
Create your free account to connect with Universidad de Alicante and thousands of other innovative organizations and professionals worldwide
A Spanish Research Group has developed a system to help in the recognition of a melanoma through the visual characteristics of an image of the skin lesion. This system can be used as an automated way to decide the urgency to refer a patient to the dermatologist.
New and innovative aspects
Main advantages of its use
Specifications
The melanoma is a type of skin cancer very aggressive and with a high incidence in many countries like Australia, USA or European Mediterranean countries; unfortunately, each year the number of patients is increasing. In spite of the aggressiveness of this kind of cancer, if it is removed in early phases, the results for the patients are very good. Otherwise, if it is not diagnosed in early phases the life expectance is reduced considerably. Therefore it is fundamental to diagnose as soon as possible a skin lesion and to distinguish a melanoma from benign lesions (a simple spot or a mole). Dermatologists encourage people to self-exploring and to go to doctor if they observe a suspected skin lesion or if it is changed in a period of time.
To identify a melanoma, dermatologists use several techniques which have been developed based on experience. All these techniques allow identifying symptoms of a malignant lesion based on the observation of a series of characteristics. It is important to bear in mind that the diagnosis of a melanoma through the visual interpretation of the characteristics of the lesion is a difficult task.
The Spanish Research Group has developed a system to help in the recognition of a melanoma through the visual characteristics of an image of the skin lesion. This system can be used as an automated way to decide the urgency to refer a patient to the dermatologist. The decision support system for melanoma diagnosis studied has three phases: first, a preprocessing of the images which includes the segmentation process; next, the selection of characteristics used to classify the image; finally, the classification of the lesion. In the preprocessing phase, the system carries out some tasks to prepare the image to be analysed. All the digital images have impulse noise which can be reduced applying a filter. Another task of the preprocessing phase is the segmentation. The objective is to split objects of the scenario to get just the lesion area from the image. For the selection of characteristics, the software is based on the ABCD rule (Asymmetry, Border, Colour, Diameter). It obtains a set of characteristics divided into three groups: one related to the shape, other to the border and the last one to the colour. The software developed use a selection of the set of characteristics that gives the best results.
The last phase of the system is the classification of the images in two classes: benign lesions or melanoma. For the final classification the software uses the combination of several independent classifiers. The classification rates for the system are higher than 90%. This can be incremented by using it because this system can self-learn. This software is fully developed and available for demonstration. The researchers are looking for medical services that trained and, after, validate this software with dermatoscopic images and companies acquiring this technology for exploitation, although the group is open to other kind of collaboration.
Applications
The software described is an expert system that can help to the doctor for melanoma diagnosis.
This system can be applied in the detection of other diseases which are diagnosed by image analysis.
Intellectual property status
The system is protected by Intellectual Property Rights under copyright.
Current development status
Available for demonstration
Desired business relationship
Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.
Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.
Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.
Create your free account to connect with Universidad de Alicante and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Universidad de Alicante
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support